Reducing the toxicity associated with the use of radiotherapy in men with localized prostate cancer (Q35763115)

10 August 2017

1 reference

title

Reducing the toxicity associated with the use of radiotherapy in men with localized prostate cancer (English)

1 reference

10 August 2017

1 reference

1

Mack Roach

1 reference

10 August 2017

publication date

1 May 2004

1 reference

Urologic Clinics of North America

10 August 2017

published in

1 reference

10 August 2017

volume

31

1 reference

10 August 2017

issue

2

1 reference

10 August 2017

page(s)

353-366

1 reference

Radiation-associated morbidity in patients undergoing small-field external beam irradiation for prostate cancer

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Complications after prostate brachytherapy in the Medicare population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Long-term urinary quality of life after permanent prostate brachytherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Dysuria after permanent prostate brachytherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

A pilot survey of sexual function and quality of life following 3D conformal radiotherapy for clinically localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Radiation-induced decrease in nitric oxide synthase--containing nerves in the rat penis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Prospective pilot study of sildenafil for treatment of postradiotherapy erectile dysfunction in patients with prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Potency after permanent prostate brachytherapy for localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Acute toxicity during external-beam radiotherapy for localized prostate cancer: comparison of different techniques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

The "critical volume tolerance method" for estimating the limits of dose escalation during three-dimensional conformal radiotherapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Intensity-modulated radiotherapy: current status and issues of interest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Forward or inversely planned segmental multileaf collimator IMRT and sequential tomotherapy to treat multiple dominant intraprostatic lesions of prostate cancer to 90 Gy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Clinical experience with intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of rectal balloon for prostate immobilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Organ motion and its management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Interobserver variability leads to significant differences in quantifiers of prostate implant adequacy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Initial clinical assessment of CT-MRI image fusion software in localization of the prostate for 3D conformal radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

(Non)-migration of radiopaque markers used for on-line localization of the prostate with an electronic portal imaging device

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Evaluation of ultrasound-based prostate localization for image-guided radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Predictive factors of acute urinary morbidity after iodine-125 brachytherapy for localised prostate cancer: a phase 2 study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Prostatourethral-rectal fistula after prostate brachytherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Dosimetric and radiographic correlates to prostate brachytherapy-related rectal complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Probability of late rectal morbidity in 125I prostate brachytherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Myths and fallacies in permanent prostate brachytherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Iodine-125 brachytherapy for localized prostate cancer and urinary morbidity: a prospective comparison of two seed implant methods-preplanning and intraoperative planning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Acute and late radiotherapy toxicity in patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Prostate brachytherapy in patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Diabetes mellitus: a predictor for late radiation morbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

High-dose rate interstitial with external beam irradiation for localized prostate cancer--results of a prospective trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Urinary incontinence following external-beam radiotherapy for clinically localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Low risk of urinary incontinence following prostate brachytherapy in patients with a prior transurethral prostate resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Adjuvant androgen deprivation impacts late rectal toxicity after conformal radiotherapy of prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Prostate brachytherapy in patients with prostate volumes >/= 50 cm(3): dosimetic analysis of implant quality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Effects of pelvic rotation and needle angle on pubic arch interference during transperineal prostate implants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Late urinary function after prostate brachytherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Temporal resolution of urinary morbidity following prostate brachytherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Topical Application of WR-2721 Achieves High Concentrations in the Rectal Wall

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Endoscopic scoring of late rectal mucosal damage after conformal radiotherapy for prostatic carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Amifostine as radioprotective agent for the rectal mucosa during irradiation of pelvic tumors. A phase II randomized study using various toxicity scales and rectosigmoidoscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Amifostine and external beam radiation therapy and/or high-dose rate brachytherapy in the treatment of localized prostate carcinoma: preliminary results of a phase II trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Clinical trial of endorectal amifostine for radioprotection in patients with prostate cancer: rationale and early results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

Conformal static field radiation therapy treatment of early prostate cancer versus non-conformal techniques: a reduction in acute morbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2004.02.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UCL.2004.02.001

1 reference

10 August 2017

1 reference